Langhe Medical
Focused on early detection and non-invasive treatment, we aim to be the comprehensive provider for precise respiratory intervention solutions.
Focused on early detection and non-invasive treatment, we aim to be the comprehensive provider for precise respiratory intervention solutions.
Langhe Medical, a **Health Care** and **Robotics** startup, founded in **2015**, focuses on **early detection** and **non-invasive treatment** of lung cancer. With the slogan "Focused on early detection and non-invasive treatment, we aim to be the comprehensive provider for precise respiratory intervention solutions," the company aspires to provide a complete solution for precise diagnosis and treatment within respiratory intervention. The latest milestone for Langhe Medical was the **CNY100.00M Series C** investment on **12 December 2023**, led by **Shangguo Investment Management** and **Jiuyou Fund**. This substantial investment signifies high confidence from some notable names in the industry, indicating the potential for Langhe Medical's innovative solutions to make significant advancements in the field of respiratory intervention.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series C | CNY100.00M | 2 | Shangguo Investment Management, Jiuyou Fund | 12 Dec 2023 |
| Series B | Unknown | 2 | TaiKun Fund, Yinglian Health Fund | 19 Apr 2022 |
No recent news or press coverage available for Langhe Medical.
We care about your data, and we'd love to use cookies make your experience better.